Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
BeOne Medicines
BeOne Medicines
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoosier Cancer Research Network
Memorial Sloan Kettering Cancer Center
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
EMD Serono
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Chang Gung Memorial Hospital
Alliance for Clinical Trials in Oncology
BeOne Medicines
Fox Chase Cancer Center
Mayo Clinic
University of Oklahoma
M.D. Anderson Cancer Center
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Emory University
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Jonsson Comprehensive Cancer Center
Genentech, Inc.
Brigham and Women's Hospital
University of Utah
EMD Serono